Cost-Effectiveness of Early Intervention: Comparison between Intraluminal Bronchoscopic Treatment and Surgical Resection for T1N₀ Lung Cancer Patients
Authors:
- Hes A.P. BrokxHBHes A.P. Brokx
- Anton Vonk NoordegraafANAnton Vonk Noordegraaf
- Rick M.A. PaulRPRick M.A. Paul
- Pieter E. PostmusPPPieter E. Postmus
- Tom G. SutedjaTSTom G. Sutedja
- 1 August 2004
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 71 (4) , 391-396
Abstract
Background: For patients with early-stage lung cancer (ESLC) and severe comorbidities, the cost-effectiveness of early intervention may be reduced by screening and treatment-related morbidity and mortality in addition to the risk for non-cancer-related deaths. Objectives: The use of bronchoscopic treatment (BT) for centrally located ESLC as minimally invasive technique has raised questions whether this approach will be more cost-effective than standard surgical resection in the above-mentioned cohort of patients. Methods: The cost-effectiveness of BT of 32 medically inoperable patients with intraluminal tumor has been compared to a matched control group of surgically treated stage IA cancer patients. Results: Median follow-up after BT for ESLC has been 5 years (range 2–10) versus 6.7 years (range 2–10) for the surgical group. Five patients (16%) developed subsequent primaries/local recurrences after BT versus 4 (12.5%) in the surgical group. The respective percentages of actual survival during follow-up have been 50 and 41%, non-lung-cancer-related death 22 and 31% and lung-cancer-related death 28% in both groups, respectively. So far, the average costs per individual for early management by BT have been Euro 22,638 by surgery, and total expenses have been Euro 209,492 and Euro 724,403, respectively. Conclusions: Despite the worse initial health status of patients treated with BT, actual survival rates and costs for early intervention underscore the superior cost-effectiveness of BT as early intervention in properly selected individuals with ESLC in the central airways.Keywords
This publication has 8 references indexed in Scilit:
- Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up studyLung Cancer, 2003
- Screening for Lung Cancer*Chest, 2003
- Autofluorescence Bronchoscopy Improves Staging of Radiographically Occult Lung Cancer and Has an Impact on Therapeutic StrategyChest, 2001
- Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experienceThe Annals of Thoracic Surgery, 2001
- Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose?Lung Cancer, 2001
- What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent?: Retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squamous cell carcinomaLung Cancer, 1998
- Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive techniqueEuropean Respiratory Journal, 1998
- High resolution computed tomography in patients referred for intraluminal bronchoscopic therapy with curative intentEuropean Respiratory Journal, 1996